Abdul-Fattah S, Pal A, Kaka N, Kakodkar P (2021) History and recent advances in coronavirus discovery. In: Roy K (ed) In silico modeling of drugs against coronaviruses. Methods in pharmacology and toxicology. Humana, New York. https://doi.org/10.1007/7653_2020_47
Chapter
Google Scholar
Agrahari R, Mohanty S, Vishwakarma K, Nayak SK, Samantaray D, Mohapatra S (2021) Update vision on COVID-19: structure, immune pathogenesis, treatment and safety assessment. Sens Int 2:100073. https://doi.org/10.1016/j.sintl.2020.100073
Article
PubMed
Google Scholar
Al-Tawfiq JA, Arabi Y (2020) Convalescent plasma therapy for coronavirus infection: experience from MERS and application in COVID-19. Hum Vaccines Immunother 16(12):2973–2979. https://doi.org/10.1080/21645515.2020.1793712
Article
CAS
Google Scholar
Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF (2020) The proximal origin of SARS-CoV-2. Nat Med 26(4):450–452. https://doi.org/10.1038/s41591-020-0820-9
Article
CAS
PubMed
Google Scholar
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J (2021) Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med 384(5):403–416. https://doi.org/10.1056/nejmoa2035389
Article
CAS
PubMed
Google Scholar
Balkhair A, Al-Zakwani I, Al Busaidi M, Al-Khirbash A, Al Mubaihsi S, BaTaher H, Al Aghbari J, Al Busaidi I, Al Kindi M, Baawain S, Al Alawi A (2021) Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study. Int J Infect Dis 103:288–296. https://doi.org/10.1016/j.ijid.2020.11.149
Article
CAS
PubMed
Google Scholar
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D (2020) Remdesivir for the treatment of Covid-19—final report. N Engl J Med 383(19):1813–1826. https://doi.org/10.1056/nejmoa2007764
Article
CAS
PubMed
Google Scholar
Boopathi S, Poma AB, Kolandaivel P (2021) Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn 39(9):3409–3418. https://doi.org/10.1080/07391102.2020.1758788
Article
CAS
PubMed
Google Scholar
Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 383(6):517–525. https://doi.org/10.1056/nejmoa2016638
Article
CAS
PubMed
Google Scholar
Bravo L, Smolenov I, Han HH, Li P, Hosain R, Rockhold F, Clemens SA, Roa C Jr, Borja-Tabora C, Quinsaat A, Lopez P (2022) Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial. Lancet 399(10323):461–472. https://doi.org/10.1016/s0140-6736(22)00055-1
Article
CAS
PubMed
PubMed Central
Google Scholar
Burrell CJ, Howard CR, Murphy FA (2017) Fenner and White’s medical virology, 5th edn. Academic Press, London, pp 437–446
Book
Google Scholar
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM (2020) The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 178:104787. https://doi.org/10.1016/j.antiviral.2020.104787
Article
CAS
PubMed
PubMed Central
Google Scholar
Cantini F, Blandizzi C, Niccoli L, Petrone L, Goletti D (2020) Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases. Expert Opin Drug Saf 19(7):861–872. https://doi.org/10.1080/14740338.2020.1774550
Article
CAS
PubMed
Google Scholar
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X (2020) A trial of Lopinavir–Ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382(19):1787–1799. https://doi.org/10.1056/nejmoa2001282
Article
CAS
PubMed
Google Scholar
Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, Rech R, Colombo R, Antinori S, Corbellino M, Galli M (2020) Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 20(10):1135–1140. https://doi.org/10.1016/s1473-3099(20)30434-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R (2022) Features, evaluation, and treatment of coronavirus (COVID-19). In: Stat Pearls. Stat Pearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554776. Accessed 29 Jan 2022
Chachar AZ, Khan KA, Iqbal J, Shahid AH, Asif M, Fatima SA, Khan AA, Younis BB (2021) “Tocilizumab-an option for patients with COVID-19 associated cytokine release syndrome: a single center experience”, a retrospective study-original article. Ann Med Surg 63:102165. https://doi.org/10.1016/j.amsu.2021.02.011
Article
Google Scholar
Chavda VP, Hossain MK, Beladiya J, Apostolopoulos V (2021) Nucleic acid vaccines for COVID-19: a paradigm shift in the vaccine development arena. Biologics 1(3):337–356. https://doi.org/10.3390/biologics1030020
Article
Google Scholar
Chen CX, Wang JJ, Li H, Yuan LT, Gale RP, Liang Y (2021) JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis. Leukemia. https://doi.org/10.1038/s41375-021-01266-6
Article
PubMed
PubMed Central
Google Scholar
Chilamakuri R, Agarwal S (2021) COVID-19: characteristics and therapeutics. Cells 10(2):206. https://doi.org/10.3390/cells10020206
Article
CAS
PubMed
PubMed Central
Google Scholar
Clapham HE, Cook AR (2021) Face masks help control transmission of COVID-19. Lancet Digit Health 3(3):e136-137. https://doi.org/10.1016/s2589-7500(21)00003-0
Article
PubMed
PubMed Central
Google Scholar
Corman VM, Muth D, Niemeyer D, Drosten C (2018) Hosts and sources of endemic human coronaviruses. Adv Virus Res 100:163–188. https://doi.org/10.1016/bs.aivir.2018.01.001
Article
CAS
PubMed
PubMed Central
Google Scholar
Coutard B, Valle C, de Lamballerie X, Canard B, Seidah N, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 176:104742. https://doi.org/10.1016/j.antiviral.2020.104742
Article
CAS
PubMed
PubMed Central
Google Scholar
Cucinotta D, Vanelli M (2020) WHO declares COVID-19 a pandemic. Acta Biomed 91(1):157–160. https://doi.org/10.23750/abm.v91i1.9397
Article
PubMed
PubMed Central
Google Scholar
Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C (2020) Effectiveness of convalescent plasma therapy in severe COVID-19 patients. PNAS 117(17):9490–9496. https://doi.org/10.1073/pnas.2004168117
Article
CAS
PubMed
PubMed Central
Google Scholar
Echeverría-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, De-Antonio Cuscó M, Ferrández O, Horcajada JP, Grau S (2021) Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther 19(2):147–163. https://doi.org/10.1080/14787210.2020.1813024
Article
CAS
PubMed
Google Scholar
Elesdoudy A (2021) Sotrovimab: is it effective in early treatment of mild and moderate COVID-19 infections? A retrospective study. Egypt J Bronchol 15:56. https://doi.org/10.1186/s43168-021-00104-8
Article
Google Scholar
Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal G, Yadav P (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis 21(7):950–961. https://doi.org/10.1016/s1473-3099(21)00070-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Fang QQ, Huang WJ, Li XY, Cheng YH, Tan MJ, Liu J, Wei HJ, Meng Y, Wang DY (2020) Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice. Virology 545:1–9. https://doi.org/10.1016/j.virol.2020.02.005
Article
CAS
PubMed
Google Scholar
Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol 1282:1–23. https://doi.org/10.1007/978-1-4939-2438-7_1
Article
CAS
PubMed
PubMed Central
Google Scholar
Gao W, Chen S, Wang K, Chen R, Guo Q, Lu J, Wu X, He Y, Yan Q, Wang S, Wang F (2020) Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID-19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series. Virol J 17(1):162. https://doi.org/10.1186/s12985-020-01428-5
Article
CAS
PubMed
PubMed Central
Google Scholar
Gasmi A, Peana M, Noor S, Lysiuk R, Menzel A, Benahmed AG, Bjørklund G (2021) Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story. Appl Microbiol Biotechnol 105(4):1333–1343. https://doi.org/10.1007/s00253-021-11094-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, Rubin R, Morales-Estrada S, Black SR, Pacilli M, Fricchione MJ (2020) First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. The Lancet 395(10230):1137–1144. https://doi.org/10.1016/s0140-6736(20)30607-3
Article
CAS
Google Scholar
Ginsburg AS, Klugman KP (2020) COVID-19 pneumonia and the appropriate use of antibiotics. Lancet Glob Health 8(12):e1453–e1454. https://doi.org/10.1016/s2214-109x(20)30444-7
Article
PubMed
PubMed Central
Google Scholar
Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS (2020) Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med 383(19):1827–1837. https://doi.org/10.1056/nejmoa2015301
Article
CAS
PubMed
Google Scholar
Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, Rota PA, Bankamp B, Bellini WJ, Zaki SR (2004) Ultrastructural characterization of SARS coronavirus. Emerg Infect Dis 10(2):320–326. https://doi.org/10.3201/eid1002.030913
Article
PubMed
PubMed Central
Google Scholar
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720. https://doi.org/10.1056/NEJMoa2002032
Article
CAS
PubMed
Google Scholar
Guo Y-R, Cao Q-D, Hong Z-S, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res 7(1):1–10. https://doi.org/10.1186/s40779-020-00240-0
Article
CAS
Google Scholar
Gupta A, Gonzalez-Rojas Y, Juarez E, Crespo Casal M, Moya J, Falci DR, Sarkis E, Solis J, Zheng H, Scott N, Cathcart AL (2021) Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab. N Engl J Med 385(21):1941–1950. https://doi.org/10.1056/NEJMoa2107934
Article
CAS
PubMed
Google Scholar
Hadj Hassine I (2021) Covid-19 vaccines and variants of concern: a review. Rev Med Virol. https://doi.org/10.1002/rmv.2313
Article
PubMed
PubMed Central
Google Scholar
Haque SM, Ashwaq O, Sarief A, Azad John Mohamed AK (2020) A comprehensive review about SARS-CoV-2. Future Virol 15(9):625–648. https://doi.org/10.2217/fvl-2020-0124
Article
CAS
PubMed
PubMed Central
Google Scholar
Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y (2020) Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg Infect Dis 26(6):1266. https://doi.org/10.3201/eid2606.200516
Article
CAS
PubMed
PubMed Central
Google Scholar
Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, Spitters C, Ericson K, Wilkerson S, Tural A, Diaz G (2020) First case of 2019 novel coronavirus in the United States. N Engl J Med 382(10):929–936. https://doi.org/10.1056/nejmoa2001191
Article
PubMed
PubMed Central
Google Scholar
Horby P, Mafham M, Linsell L et al (2020) Effect of hydroxychloroquine in hospitalized patients with Covid-19. N Engl J Med 383(21):2030–2040. https://doi.org/10.1056/nejmoa2022926
Article
CAS
PubMed
Google Scholar
Huang Y, Yang C, Xu X-f, Xu W, Liu S-w (2020) Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 41(9):1141–1149. https://doi.org/10.1038/s41401-020-0485-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Huang B, Wang J, Cai J, Yao S, Chan PK, Tam TH, Hong YY, Ruktanonchai CW, Carioli A, Floyd JR, Ruktanonchai NW (2021) Integrated vaccination and physical distancing interventions to prevent future COVID-19 waves in Chinese cities. Nat Hum Behav 5(6):695–705. https://doi.org/10.1038/s41562-021-01063-2
Article
PubMed
Google Scholar
Johnson G, Morawska L, Ristovski Z, Hargreaves M, Mengersen K, Chao CY, Wan MP, Li Y, Xie X, Katoshevski D, Corbett S (2011) Modality of human expired aerosol size distributions. J Aerosol Sci 42(12):839–851. https://doi.org/10.1016/j.jaerosci.2011.07.009
Article
CAS
ADS
Google Scholar
Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24(11):S223–S227. https://doi.org/10.1097/01.inf.0000188166.17324.60
Article
PubMed
Google Scholar
Kalil AC, Patterson TF, Mehta AK, Omashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V (2021) Baricitinib plus Remdesivir for hospitalized adults with Covid-19. N Engl J Med 384(9):795–807. https://doi.org/10.1056/nejmoa2031994
Article
CAS
PubMed
Google Scholar
Kmietowicz Z (2022) Covid-19: WHO recommends baricitinib and sotrovimab to treat patients. BMJ 376:o97. https://doi.org/10.1136/bmj.o97
Article
PubMed
Google Scholar
Lau SKP, Luk HKH, Wong ACP, Li KS, Zhu L, He Z, Fung J, Chan TT, Fung KS, Woo PC (2020) Possible bat origin of severe acute respiratory syndrome coronavirus 2. Emerg Infect Dis 26(7):1542–1547. https://doi.org/10.3201/eid2607.200092
Article
CAS
PubMed
PubMed Central
Google Scholar
Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharullaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Erokhova AS, Botikov AG (2021) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 397(10275):671–681. https://doi.org/10.1016/s0140-6736(21)00234-8
Article
CAS
PubMed
PubMed Central
Google Scholar
Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 92(7):814–818. https://doi.org/10.1002/jmv.25801
Article
CAS
PubMed
Google Scholar
Manabe T, Kambayashi D, Akatsu H, Kudo K (2021) Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis 21(1):489. https://doi.org/10.1186/s12879-021-06164-x
Article
CAS
PubMed
PubMed Central
Google Scholar
Mangkuliguna G, Glenardi SN, Pramono LA (2021) Efficacy and safety of Azithromycin for the treatment of COVID-19: a systematic review and meta-analysis. Tuberc Respir Dis (Seoul). https://doi.org/10.4046/trd.2021.0075
Article
Google Scholar
Marano G, Vaglio S, Pupella S, Facco G, Catalano L, Liumbruno GM, Grazzini G (2016) Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus 14(2):152–157. https://doi.org/10.2450/2015.0131-15
Article
PubMed
PubMed Central
Google Scholar
Matthay MA, Thompson BT (2020) Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties. Lancet Respir Med 8(12):1170–1172. https://doi.org/10.1016/s2213-2600(20)30503-8
Article
CAS
PubMed
PubMed Central
Google Scholar
Mitjà O, Corbacho-Monné M, Ubals M, Alemany A, Suñer Navarro C, Tebé C, Tobias A, Peñafiel J, Ballana E, Pérez CA, Admella P (2021) A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19. N Engl J Med 384(5):417–427. https://doi.org/10.1056/nejmoa2021801
Article
CAS
PubMed
Google Scholar
Mousavizadeh L, Ghasemi S (2020) Genotype and phenotype of COVID-19: their roles in pathogenesis. J Microbiol Immunol Infect 54(2):159–163. https://doi.org/10.1016/j.jmii.2020.03.022
Article
CAS
PubMed
PubMed Central
Google Scholar
Nojomi M, Yassin Z, Keyvani H, Makiani MJ, Roham M, Laali A, Dehghan N, Navaei M, Ranjbar M (2020) Effect of Arbidol (Umifenovir) on COVID-19: a randomized controlled trial. BMC Infect Dis 20(1):954. https://doi.org/10.1186/s12879-020-05698-w
Article
CAS
PubMed
PubMed Central
Google Scholar
Oldenburg CE, Doan T (2020) Azithromycin for severe COVID-19. Lancet 396(10256):936–937. https://doi.org/10.1016/S0140-6736(20)31863-8
Article
CAS
PubMed
PubMed Central
Google Scholar
Omokhua-Uyi AG, Van Staden J (2021) Natural product remedies for COVID-19: a focus on safety. S Afr J Bot 139:386–398. https://doi.org/10.1016/j.sajb.2021.03.012
Article
CAS
PubMed
PubMed Central
Google Scholar
Paden CR, Yusof M, Al Hammadi ZM, Ueen K, Tao Y, Eltahir YM, Elsayed EA, Marzoug BA, Bensalah OK, Khalafalla AI, Al Mulla M (2018) Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE. Zoonoses Public Health 65(3):322–333. https://doi.org/10.1111/zph.12435
Article
CAS
PubMed
Google Scholar
Pal M, Berhanu G, Desalegn C, Kandi V (2020) Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus 12(3):e7423. https://doi.org/10.7759/cureus.7423
Article
PubMed
PubMed Central
Google Scholar
Pani A, Lauriola M, Romandini A, Scaglione F (2020) Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int J Antimicrob Agents 56(2):106053. https://doi.org/10.1016/j.ijantimicag.2020.106053
Article
CAS
PubMed
PubMed Central
Google Scholar
Panyod S, Ho CT, Sheen LY (2020) Dietary therapy and herbal medicine for COVID-19 prevention: a review and perspective. J Tradit Complement Med 10(4):420–427. https://doi.org/10.1016/j.jtcme.2020.05.004
Article
PubMed
PubMed Central
Google Scholar
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Marc GP, Moreira ED, Zerbini C, Bailey R (2020) Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 383(27):2603–2615. https://doi.org/10.1056/nejmoa2034577
Article
CAS
PubMed
Google Scholar
Praveen D, Puvvada RC, Vijey Aanandhi M (2020) Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19. Int J Antimicrob Agents 55(5):105967. https://doi.org/10.1016/j.ijantimicag.2020.105967
Article
CAS
PubMed
PubMed Central
Google Scholar
Réa-Neto Á, Bernardelli RS, Câmara BMD, Reese FB, Queiroga MVO, Oliveira MC (2021) An open-label randomized controlled trial evaluating the efficacy of chloroquine/hydroxychloroquine in severe COVID-19 patients. Sci Rep 11(1):9023. https://doi.org/10.1038/s41598-021-88509-9
Article
CAS
PubMed
PubMed Central
ADS
Google Scholar
Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 395(10223):e30–e31. https://doi.org/10.1016/s0140-6736(20)30304-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, Goepfert PA, Truyers C, Fennema H, Spiessens B, Offergeld K (2021) Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med 384(23):2187–2201
Article
CAS
PubMed
Google Scholar
Saxena SK, Kumar S, Maurya VK, Sharma R, Dandu HR, Bhatt MLB (2020) Current insight into the novel coronavirus disease 2019 (COVID-19). In: Saxena SK (ed) Coronavirus disease 2019 (COVID-19), vol 30. Springer, Singapore, pp 1–8. https://doi.org/10.1007/978-981-15-4814-7_1
Chapter
Google Scholar
Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 323(16):1582–1589. https://doi.org/10.1001/jama.2020.4783
Article
CAS
PubMed
PubMed Central
Google Scholar
Shinde V, Bhikha S, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MS, Moodley D, Hanley S, Fouche L (2021) Efficacy of NVX-CoV2373 Covid-19 vaccine against the B.1.351 variant. N Engl J Med 384(20):1899–1909. https://doi.org/10.1056/nejmoa2103055
Article
CAS
PubMed
PubMed Central
Google Scholar
Shiraki K, Daikoku T (2020) Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther 209:107512. https://doi.org/10.1016/j.pharmthera.2020.107512
Article
CAS
PubMed
PubMed Central
Google Scholar
Tharaux P-L, Pialoux G, Pavot A, Mariette X, Hermine O, Resche-Rigon M, Porcher R, Ravaud P, Bureau S, Dougados M, Tibi A (2021) Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial. Lancet Respir Med 9(3):295–304. https://doi.org/10.1016/s2213-2600(20)30556-7
Article
CAS
Google Scholar
US FDA (2021) Coronavirus (COVID-19) drugs. https://www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid-19-drugs. Accessed 18 July 2021
Valenzuela-Almada MO, Putman MS, Duarte-García A (2021) The protective effect of rheumatic disease agents in COVID-19. Best Pract Res Clin Rheumatol 35(1):101659. https://doi.org/10.1016/j.berh.2021.101659
Article
PubMed
PubMed Central
Google Scholar
Vankadari N (2020) Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein. Int J Antimicrob Agents 56(2):105998. https://doi.org/10.1016/j.ijantimicag.2020.105998
Article
CAS
PubMed
PubMed Central
Google Scholar
Voysey M, Clemens SAC, Madhi SA et al (2021) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397(10269):99–111. https://doi.org/10.1016/s0140-6736(20)32661-1
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30(3):269–271. https://doi.org/10.1038/s41422-020-0282-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Wertheim JO, Chu DK, Peiris JS, Kosakovsky Pond SL, Poon LL (2013) A case for the ancient origin of coronaviruses. J Virol 87(12):7039–7045. https://doi.org/10.1128/jvi.03273-12
Article
CAS
PubMed
PubMed Central
Google Scholar
WHO (2022a) Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed 28 Jan 2022a
WHO (2022b) Tracking SARS-CoV-2 variants. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants. Accessed 28 Jan 2022b
WHO (2022c) Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. Accessed Jan 29 2022c
Wu S, Huang J, Zhang Z, Wu J, Zhang J, Hu H, Zhu T, Zhang J, Luo L, Fan P, Wang B (2021) Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Lancet Infect Dis 21(12):1654–1664. https://doi.org/10.1016/s1473-3099(21)00396-0
Article
CAS
PubMed
PubMed Central
Google Scholar
Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W (2021) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis 21(1):39–51. https://doi.org/10.1016/s1473-3099(20)30831-8
Article
CAS
PubMed
Google Scholar
Yang S, Li Y, Dai L, Wang J, He P, Li C, Fang X, Wang C, Zhao X, Huang E, Wu C (2021) Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis 21(8):1107–1119. https://doi.org/10.1016/s1473-3099(21)00127-4
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang T, Wu Q, Zhang Z (2020) Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Curr Biol 30(7):1346-1351.e1342. https://doi.org/10.1016/j.cub.2020.03.022
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X (2021) Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis 21(2):181–192. https://doi.org/10.1016/s1473-3099(20)30843-4
Article
CAS
PubMed
Google Scholar
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY (2020a) Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395(10240):1845–1854. https://doi.org/10.1016/s0140-6736(20)31208-3
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu H, Wei L, Niu P (2020b) The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy 5:6. https://doi.org/10.1186/s41256-020-00135-6
Article
PubMed
PubMed Central
Google Scholar